September 29, 2022

Efficacy and Safety of Oral Semaglutide 25mg once daily in adults with overweight and obesity

The UAB Department of Nutrition Sciences is conducting a 71-week research study to evaluate the effectiveness of an investigational drug to treat overweight and obesity. In this trial, participants will receive once daily oral semaglutide tablet or placebo along with diet and exercise counseling. To qualify, you must be 18 years old or older and be overweight or obese without diabetes. For more information, and to see if you might be eligible to join, please contact (205)975-8217 or mcr90@uab.edu.